Comparison of diagnostic criteria for polycythaemia vera

Richard C Turkington1, E Claire Arnold, Melanie J Percy

  • 1Department of Haematology, Queen's University Belfast, Belfast City Hospital, Lisburn Road, Belfast, Northern Ireland, BT9 7AB. UK.

Insights

The British Committee for Standards in Haematology (BCSH) criteria are the most accurate for diagnosing polycythaemia vera (PV), effectively distinguishing it from other erythrocytosis types. This study evaluated diagnostic criteria for PV, finding BCSH criteria superior in accuracy and differentiation.

Area of Science:

  • Hematology
  • Diagnostic Criteria Evaluation
  • Erythrocytosis Research

Background:

  • Polycythaemia vera (PV) diagnosis relies on specific criteria, with historical sets including Polycythaemia Vera Study Group (PVSG), British Committee for Standards in Haematology (BCSH), and World Health Organisation (WHO).
  • Accurate differentiation of PV from secondary, apparent, and idiopathic erythrocytosis is crucial for appropriate patient management.
  • Evaluating the diagnostic performance of existing criteria is essential for refining clinical practice.

Purpose of the Study:

  • To compare the diagnostic accuracy of PVSG, BCSH, and WHO criteria for polycythaemia vera (PV).
  • To assess the ability of each criterion set to differentiate PV from other forms of erythrocytosis.
  • To identify the most reliable diagnostic criteria for PV in a clinical cohort.

Main Methods:

  • A cohort of 71 erythrocytosis patients from Belfast City Hospital was retrospectively analyzed.
  • Patient data at diagnosis was assessed against PVSG (1975), BCSH (1996), and WHO (2001) criteria, with BCSH used as the comparator.
  • Sensitivity and specificity were calculated for each criterion set; Janus kinase 2 (JAK2) V617F mutation status was also recorded.

Main Results:

  • The BCSH criteria classified 73.9% of PV patients correctly.
  • WHO criteria demonstrated 100% sensitivity and specificity for PV but showed reduced specificity for idiopathic (66.7%) and apparent (87.5%) erythrocytosis compared to BCSH.
  • PVSG criteria had 50% sensitivity and specificity for PV due to data limitations; JAK2 V617F mutation was present in 85.3% of PV cases.

Conclusions:

  • The BCSH criteria are identified as the most accurate for diagnosing polycythaemia vera (PV).
  • BCSH criteria offer an acceptable sensitivity level while effectively differentiating PV from other erythrocytosis subtypes.
  • The study supports the use of BCSH criteria for reliable PV diagnosis in clinical settings.